SCP
TMO icon

Stevens Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Stevens Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$683K Sell
1,389
-57
-4% -$30.9K 0.16% 74
2025
Q4 		$838K Buy
1,446
+85
+6% +$48.1K 0.22% 60
2025
Q3 		$660K Buy
+1,361
New +$633K 0.2% 61

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stevens Capital Partners's TMO Position: Q1 2026 in Review

Stevens Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.9% in Q1 2026, selling an estimated $30.9K and leaving 1,389 shares worth $683K. The position accounts for 0.16% of the portfolio, ranked #74.

Stevens Capital Partners first reported a position in TMO in Q3 2025 and has held it in 3 quarters since. The position peaked at $838K in Q4 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stevens Capital Partners held 1,389 shares of Thermo Fisher Scientific worth $683K as of Q1 2026.
  • Stevens Capital Partners sold 57 Thermo Fisher Scientific shares in Q1 2026, an estimated $30.9K.
  • Thermo Fisher Scientific made up 0.16% of Stevens Capital Partners's portfolio in Q1 2026, its #74 holding.
  • Stevens Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 3 quarters since.
  • Stevens Capital Partners's Thermo Fisher Scientific position peaked at $838K in Q4 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stevens Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.